Targeted therapy - state-of-the-art treatment option for advanced non-hodgkin lymphomas
Introduction: Non-Hodgkin lymphomas (NHL) are the most common hematologic malignancies within the structure of morbidity by malignant tumors, exhibiting in generalized stages a recurrent evolution and unfavorable prognosis, with negative socio-economic effects. Predominantly late diagnosis, increas...
Main Authors: | V. Musteata, T. Rosca |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-09-01
|
Series: | Hematology Reports |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8923 |
Similar Items
-
Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
by: Hélène Vellemans, et al.
Published: (2021-07-01) -
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
by: Natalie S. Grover, et al.
Published: (2015-09-01) -
Targeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and Future
by: Caryn E. Sorge, et al.
Published: (2016-05-01) -
Hodgkin Lymphoma : Studies of Advanced Stages, Relapses and the Relation to Non-Hodgkin Lymphomas
by: Amini, Rose-Marie
Published: (2002) -
Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
by: Giulia Motta, et al.
Published: (2010-01-01)